BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30514509)

  • 41. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
    Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
    Trollip AP; Moore D; Coronel J; Caviedes L; Klages S; Victor T; Romancenco E; Crudu V; Ajbani K; Vineet VP; Rodrigues C; Jackson RL; Eisenach K; Garfein RS; Rodwell TC; Desmond E; Groessl EJ; Ganiats TG; Catanzaro A
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):227-32. PubMed ID: 24429318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay.
    Sethi S; Sharma S; Sharma SK; Meharwal SK; Jindal SK; Sharma M
    Indian J Med Res; 2004 Nov; 120(5):468-71. PubMed ID: 15591631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples.
    Affolabi D; Odoun M; Sanoussi N; Martin A; Palomino JC; Kestens L; Anagonou S; Portaels F
    J Clin Microbiol; 2008 Oct; 46(10):3243-5. PubMed ID: 18753346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction.
    Chen ML; Doddi A; Royer J; Freschi L; Schito M; Ezewudo M; Kohane IS; Beam A; Farhat M
    EBioMedicine; 2019 May; 43():356-369. PubMed ID: 31047860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela].
    Mendoza R; De Donato M; de Waard JH; Takiff H; Bello T; Chirinos G
    Invest Clin; 2010 Dec; 51(4):445-55. PubMed ID: 21365873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays.
    Affolabi D; Sanoussi N; Odoun M; Martin A; Koukpemedji L; Palomino JC; Kestens L; Anagonou S; Portaels F
    J Med Microbiol; 2008 Aug; 57(Pt 8):1024-1027. PubMed ID: 18628506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct drug susceptibility testing of Mycobacterium tuberculosis to primary anti-tubercular drugs by nitrate reductase assay.
    Mishra B; Muralidharan S; Srinivasa H
    Indian J Pathol Microbiol; 2009; 52(3):343-4. PubMed ID: 19679956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
    Baylan O
    Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

  • 56. Utility of pyrosequencing for rapid detection of tubercular meningitis (TBM) and associated susceptibility directly from CSF specimens.
    Ajbani K; Kazi M; Naik S; Soman R; Shetty A; Rodrigues C
    Tuberculosis (Edinb); 2018 Jul; 111():54-56. PubMed ID: 30029915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India.
    Gupta A; Sen MR; Mohapatra TM; Anupurba S
    J Health Popul Nutr; 2011 Feb; 29(1):20-5. PubMed ID: 21528787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis.
    Martin A; Montoro E; Lemus D; Simboli N; Morcillo N; Velasco M; Chauca J; Barrera L; Ritacco V; Portaels F; Palomino JC
    J Microbiol Methods; 2005 Nov; 63(2):145-50. PubMed ID: 15893391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.